Table 2 Sensitivity and specificity at different thresholds for qSOFA and SIRS for various clinical outcomes of included patients
Variable | qSOFA | SIRS | |||||
|---|---|---|---|---|---|---|---|
≥1 | ≥2 | ≥3 | ≥1 | ≥2 | ≥3 | ≥4 | |
In-hospital mortality | |||||||
Sensitivity, % (95% CI)a | 100 (88–100) | 90 (73–98) | 48 (29–68) | 100 (88–100) | 93 (77–99) | 83 (64–92) | 31 (15–51) |
Specificity, % (95% CI)a | 7 (3–13) | 42 (33–52) | 86 (79–92) | 0 (0–3) | 12 (7–19) | 37 (28–46) | 76 (67–83) |
ICU-free daysb | |||||||
Sensitivity, % (95% CI) | 99 (92–100) | 76 (65–86) | 28 (18–40) | 100 (95–100) | 92 (83–97) | 71 (59–81) | 26 (17–38) |
Specificity, % (95% CI) | 10 (4–18) | 48 (36–59) | 86 (77–93) | 0 (0–5) | 14 (7–23) | 36 (26–48) | 75 (64–84) |
Ventilator-free daysb | |||||||
Sensitivity, % (95% CI) | 99 (93–100) | 74 (62–83) | 29 (19–41) | 100 (95–100) | 93 (85–98) | 72 (60–82) | 29 (19–41) |
Specificity, % (95% CI) | 10 (4–19) | 45 (34–57) | 88 (78–94) | 0 (0–5) | 15 (8–25) | 38 (27–49) | 78 (67–86) |
Any organ dysfunction-free daysb | |||||||
Sensitivity, % (95% CI) | 96 (89–99) | 68 (57–79) | 28 (18–39) | 100 (95–100) | 89 (80–95) | 68 (57–79) | 25 (16–36) |
Specificity, % (95% CI) | 8 (3–16) | 41 (30–53) | 87 (77–94) | 0 (0–5) | 12 (6–21) | 34 (24–46) | 74 (62–83) |
Renal dysfunction-free daysb | |||||||
Sensitivity, % (95% CI) | 95 (87–99) | 70 (58–80) | 26 (17–38) | 100 (95–100) | 88 (79–94) | 68 (57–79) | 26 (17–38) |
Specificity, % (95% CI) | 7 (2–15) | 42 (31–54) | 86 (76–93) | 0 (0–5) | 11 (5–20) | 34 (24–46) | 75 (64–84) |